AASLD The Liver Meeting 2021 (Videos)

Our Attendees Include:

• Adult and pediatric hepatology experts.
• Clinical, basic, and translational researchers.
• Specialists who diagnose and treat liver disease, including gastroenterologists, surgeons, clinical pathologists, anesthesiologists, and radiologists.
• Primary care physicians.
• Nurse practitioners, registered nurses, physician assistants, pharmacists, and other allied health professionals in hepatology and the disciplines listed above.
• Trainees, and students in the disciplines listed above.
• Patient advocates and patients.

Topics : 

• – 2021 Academic Debates
• – AASLD & AASLD Foundation Awards & Honors Ceremony
• – AASLD Distinguished Award
• – AASLD_ALEH Joint Symposium
• – AASLD_ASGE Endoscopy Course Live Q&A Session
• – AASLD_ILTS Transplant Course Live Q&A Session
• – Alcohol, Cancer, Fibrosis Cirrhosis Portal Hypertension
• – Alcohol, NASH and NAFLD
• – Alcohol-associated Liver Disease
• – Associates, Health Outcomes, Fibrosis Cirrhosis Portal Hypertension, TransplantLiver Failure
• – Basic Translational Science, Microbiome Genomics Personalized Medicine
• – Basic Science Debrief
• – Cancer, Transplant Liver Failure, NASH and NAFLD
• – Career Development Workshop
• – Cholestatic and Autoimmune Liver Diseases
• – Cirrhosis Improving Quality through Patient Empowerment
• – Clinical Hepatology Debrief
• – Clinical Research Workshop – Part I
• – Clinical Research Workshop – Part II
• – COVID-19 and the Liver Symposium
• – Diversity Workshop
• – Emerging Trends Symposium
• – Fibrosis Cirrhosis Portal Hypertension, TransplantLiver Failure, Pediatric
• – Grit, Grace, Gratitude, and Resilience What You Wish Your Doctors Knew About You
• – HBV Cure How Close Are We
• – HBV Global Symposium
• – Health Outcomes, Fibrosis Cirrhosis Portal Hypertension, TransplantLiver Failure, NASH and NAFLD
• – Health Outcomes, Public Health
• – Health Outcomes, Training and Career Development, Public Health
• – Hepatitis B
• – Hepatitis C
• – Hepatitis Debrief
• – Hepatology Associates
• – Hepatotoxicity SIG
• – Hyman J. Zimmerman Hepatotoxicity State-of-the-Art Lecture
• – Leon Schiff State-of-the-Art Lecture
• – Liver Cancer
• – Liver Cell Biology
• – Liver Fibrosis
• – Liver Transplantation and Surgery SIG
• – Making an Impact Where You Are Patient Voices as a Vehicle for Change
• – Microbiome Genomics Personalized Medicine
• – NAFLD Debrief
• – Nonalcoholic Fatty Liver Disease
• – Nutrition 101 for Patients with Chronic Liver Disease
• – Panel Discussion Saving More Lives Forward from “A Burden of Genius”
• – Parallel 1 Advances with Approved HBV Therapies
• – Parallel 2 Health Services and Public Health
• – Parallel 3 Metabolic and Genetic Disease Hemochromatosis, Wilsons Disease, Alpha-1 Antitrypsin Deficiency
• – Parallel 4 COVID-19 Clinical
• – Parallel 5 Pediatric Hepatology Metabolic and Genetic Diseases
• – Parallel 6- Experimental and Translational Portal Hypertension and ACLF – The World’s Premier Event in Hepatology
• – Parallel 7 Immunosuppression, Outcomes, Complications
• – Parallel 8 HBV Cascade of Care, Natural History and Diagnostics
• – Parallel 9 COVID-19 Translational and Clinical
• – Parallel 10 Diagnostics and Biomarkers of NAFLD
• – Parallel 11 Healthcare Quality and Access in Hepatology
• – Parallel 12 Donor and Allocation Issues, Living and Split Donor Liver Transplantation
• – Parallel 13 Novel HBV Therapies and Approaches
• – Parallel 14 Hepatitis C Oral Session
• – Parallel 15 Biomarkers and Therapeutics in Autoimmune and Cholestatic Diseases
• – Parallel 16 Experimental and Translational Advances in Alcohol-Associated Liver Disease
• – Parallel 17 NAFLD and NASH Predicting Outcomes and Response to Interventions
• – Parallel 18 Mechanisms of Cholestatic Liver Injury
• – Parallel 19 Clinical Advances in Alcohol-Associated Liver Disease
• – Parallel 20 Hepatobiliary Neoplasia Clinical Oral Session
• – Parallel 21 NAFLD and NASH Clinical Trials of Novel Therapeutics
• – Parallel 22 Portal Hypertension Risk Stratification and Treatment for Varices
• – Parallel 23 Cell and Molecular Biology
• – Parallel 24 Hepatobiliary Neoplasia Experimental Translational Oral Session
• – Parallel 25 Portal Hypertension Clinical
• – Parallel 26 Liver Fibrogenesis and Non-Parenchymal Cell Biology
• – Parallel 27 Diversity, Equity, and Inclusion in Liver Disease Care
• – Parallel 28 Gut Liver Axis and Microbiome
• – Parallel 29 NAFLD and NASH Management and Outcomes in the Clinic
• – Parallel 30- Genomics and Precision Medicine – The World’s Premier Event in Hepatology
• – Parallel 31 Clinical Translational Research in Pediatric Hepatology
• – Parallel 32 Clinical Acute on Chronic Liver Failure
• – Parallel 34 Basic Science Research in Pediatric Hepatology
• – Parallel 35 Viral Hepatitis Oral Session (Non-HBV, Non-HCV)
• – Parallel 36 Hepatotoxicity
• – Patient Annual Forum and Meet & Greet Networking
• – Patient Debrief
• – Patient Keynote How Physician-Patient Partnerships Can Improve Liver Disease Care & Research
• – Pediatric Liver Disorders and Acute on Chronic Liver Failure SIG Program – Part I Management of Acute-on-Chronic Liver Failure in Adults and Children
• – Pediatric Liver Disorders and Acute on Chronic Liver Failure SIG Program – Part II Management of Acute-on-Chronic Liver Failure in Adults and Children
• – Pediatric, Cholestatic and Autoimmune Liver Disease
• – Portal Hypertension Clinical and Experimental
• – Postgraduate Course – Part I
• – Postgraduate Course – Part II
• – Postgraduate Course – Part III
• – Postgraduate Course Live Q&A Session
• – Practice Guidelines Debrief for Patients
• – Practice Guidelines Workshop
• – Presidential Plenary Basic and Translational
• – Presidential Plenary Clinical and Translational
• – Presidential Plenary Liver Transplant
• – Presidential Welcome and President’s Choice Lecture
• – Public Health Health Care Delivery
• – The Liver Meeting Closing Remarks
• – Transplant Surgery Workshop Part I (Increased-risk Organs)
• – Transplant Surgery Workshop Part II (Living Donor, Split Liver)
• – TransplantLiver Failure, Microbiome Genomics Personalized Medicine
• – Viral Hepatitis Elimination Session
• – Women’s Health Program

Release Date : November 13-16 2021